Top Markets
Coin of the day
InNexus Biotechnology, Inc. InNexus Biotechnology, Inc.

InNexus Biotechnology, Inc.

IXSBF
Pozycja w akcjach #41696
InNexus Biotechnology, Inc. is a development-stage company dedicated to... InNexus Biotechnology, Inc. is a development-stage company dedicated to advancing and commercializing monoclonal antibodies. Its efforts are underpinned by its proprietary Dynamic Cross Linking (DXL) technology. This DXL platform is designed to boost the therapeutic efficacy of conventional monoclonal antibody treatments by strengthening their binding to target antigens, amplifying their effector functions, and endowing them with novel properties. InNexus's development portfolio features several investigational therapies: DXL625: A monoclonal antibody currently in late-stage pre-clinical development, engineered for superior binding kinetics and enhanced effector functions, intended for treating B-cell non-Hodgkin's lymphoma (NHL). DXLr120: A recombinant DXL anti-CD20 antibody also being developed for B-cell NHL. DXL702: A monoclonal antibody targeting metastatic breast cancer. DXL1218: An agent designed to target the epidermal growth factor receptor (EGFR), an antigen frequently overexpressed in metastatic colorectal cancer and squamous cell carcinomas of the head and neck. The company also maintains strategic partnerships with XERIS Pharmaceuticals, Genhelix, Evogenix, Affimed, and Corixa. InNexus Biotechnology, Inc. is based in Vancouver, Canada.
Cena akcji
$0.0001
Ostatnia synchronizacja: 2025-11-07
Kapitalizacja rynkowa
$12.63K
Zmiana (1 dzień)
0.00%
Zmiana (1 rok)
0.00%
Kraj
CA
Handel InNexus Biotechnology, Inc. (IXSBF)

Kategoria

Historia ceny akcji dla InNexus Biotechnology, Inc. (IXSBF)
Najwyższa cena zamknięcia: $0.00 dnia 2025-11-01

Najniższa cena zamknięcia: $0.54 dnia 2005-01-01
Historia cen akcji firmy InNexus Biotechnology, Inc. od 2005 do 2026
Roczna wydajność ceny akcji
Rok Wydajność
2026 (TTM) 0.00%
2025 0.00%
2024 9,900.00%
2023 -98.02%
2022 -49.50%
2021 809.09%
2020 1,000.00%
2019 -99.00%
2018 0.00%
2017 0.00%
2016 20.00%
2015 -89.80%
2014 45.43%
2013 -9.43%
2012 -75.12%
2011 -93.68%
2010 -30.02%
2009 -1.01%
2008 -76.04%
2007 -65.32%
2006 182.90%
2005 0.00%
Cena akcji podobnych firm lub konkurencji
Firma Cena akcji Zmiana 1r% Kraj
$59.08 62.03%
US
$49.68 72.21%
SE
$184.45 43.36%
FR
$62.39 4.91%
IT
$113.04 55.27%
US